Health in Dominica 904 indicators covering health for Dominica. IndicatorLatest Year10-yr change Rank Hepb3 number unvaccinated 318.12 2023 up 1,019.8% 168th Rotavirus vaccines completed dose (RotaC) immunization coverage among 0.0% 2025 — 138th Young people (ages 15-24) newly infected with HIV 100 2024 unchanged 83rd Tb related deaths hiv 0 2023 down 100.0% 158th Smoking bans in public places 0 2022 — 156th Current health expenditure (CHE) as percentage of gross domestic 5.0% 2023 down 6.4% 125th External health expenditure (EXT) as percentage of current health 2.7% 2023 up 19.2% 85th Domestic general government health expenditure (GGHE-D) as percentage 67.1% 2023 up 9.4% 64th Out-of-pocket expenditure as percentage of current health expenditure 29.3% 2023 down 17.1% 88th Domestic general government health expenditure (GGHE-D) as percentage 3.4% 2023 up 2.5% 93rd Domestic general government health expenditure (GGHE-D) as percentage 5.0% 2023 down 47.6% 167th Domestic private health expenditure (PVT-D) as percentage of current 30.2% 2023 down 17.1% 118th Current health expenditure (CHE) per capita in US$ 492.45 2023 up 28.9% 95th Domestic private health expenditure (PVT-D) per capita in US$ 148.51 2023 up 6.9% 96th Domestic general government health expenditure (GGHE-D) per capita in 330.61 2023 up 41.0% 86th Total healthcare expenditure gdp 5.01 2023 down 6.4% 125th Health expenditure government expenditure 5.03 2023 down 47.6% 166th Mumps - number of reported cases 0 2025 — 110th Incidence of tuberculosis (per 100 000 population) 0 2023 down 100.0% 175th Hib vaccine 90 2024 down 7.2% 101st Congenital Rubella Syndrome - number of reported cases 0 2025 — 16th External health expenditure (EXT) per capita in US$ 13.33 2023 up 53.6% 53rd Nursing and midwifery personnel 461 2018 down 1.7% 176th Nursing personnel 461 2018 down 1.7% 174th Number of new HIV infections per 1,000 uninfected population, by sex 0.1199 2024 down 29.2% 62nd Raised blood pressure (SBP>=140 OR DBP>=90) 39.28 2019 down 5.5% 15th Raised blood pressure (SBP>=140 OR DBP>=90) 40.51 2019 down 5.2% 14th Hypertension: diagnosis coverage among adults aged 30-79 with 57.7% 2019 up 8.9% 83rd Hypertension among adults aged 30-79 years, prevalence 47.7 2019 unchanged 12th Hypertension effective treatment coverage (controlled hypertension) 17.6% 2019 up 36.4% 97th Hypertension: effective treatment coverage (controlled hypertension) 18.0% 2019 up 38.5% 92nd Hypertension treatment coverage among adults aged 30-79 with 46.9% 2019 up 10.6% 78th Hypertension treatment coverage among adults aged 30-79 with 45.6% 2019 up 9.1% 82nd Hypertension: diagnosis coverage among adults aged 30-79 with 59.0% 2019 up 10.1% 80th Hypertension among adults aged 30-79 years, prevalence, crude 49.4 2019 up 0.6% 16th Pneumococcal conjugate second or third-dose vaccines (PCVc) 0.0% 2025 — 167th Adolescent birth rate 0.9009 2006 — 63rd Rubella number unvaccinated 115.68 2023 up 74.5% 155th Proportion of births attended by skilled health personnel 100.0% 2024 unchanged 1st Prevalence of insufficient physical activity among adults aged 18+ 30.8% 2022 up 19.4% 71st Prevalence of insufficient physical activity among adults aged 18+ 30.5% 2022 up 22.4% 70th 3.b.1 Proportion of surviving infants receiving 3 doses of 92 2022 down 5.2% 81st Nursing and midwifery personnel 67.6 2018 up 0.5% 45th Immunization measles vs vaccine safety 75 2024 down 15.7% 125th Share of children vaccinated with mcv2 75 2024 down 15.7% 125th TB patients with known HIV status 100.0% 2024 up 49.3% 1st Confirmed cases of RR-/MDR-TB 0 2024 — 169th Hib3 number unvaccinated 318.12 2023 up 1,019.8% 170th Capital health expenditure 0.2% 2023 down 16.9% 74th Adolescent birth rate 0.9009 2006 — 62nd Share of deaths from cardiovascular diseases men women 30.71 2022 down 14.1% 51st Deaths registered with an ill defined cause of death 2.32 2022 down 37.8% 74th Share of deaths from homicide 1.54 2022 up 19.3% 18th Share of deaths from major causes 3.22 2022 up 65.7% 77th Share of deaths from underlying causes 17.25 2022 down 3.1% 63rd Tested TB patients HIV-positive 20.0% 2016 down 70.1% 28th New cases tested for RR-/MDR-TB 50.0% 2024 down 50.0% 161st Tuberculosis death rate age standardized 3.62 2021 up 40.9% 105th Number of deaths in children aged <5 years, by cause 3.62 2021 up 42.8% 180th Previously treated cases tested for RR-/MDR-TB 0.0% 2024 down 100.0% 173rd ← Previous Page 11 of 16 Next →